A. Bjornerud et al., Pre-clinical results with Clariscan (TM) (NC100150 Injection); experience from different disease models, MAGN RES MA, 12(2-3), 2001, pp. 99-103
Citations number
15
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
A superparamagnetic nanoparticle (NC100150 Injection) was investigated in t
wo different animal models; renal perfusion in pigs and tumour imaging in m
ice. In the pig model, qualitative first-pass perfusion maps following a bo
lus injection of NC100150 Injection enabled good visualisation of hypoperfu
sed regions of the renal cortex following partial ligation of the renal art
ery. High temporal resolution was found to be essential to accurately captu
re the first passage of the contrast agent through the kidney due to the ve
ry rapid blood flow in normal renal cortex. In the tumour model (LS174T cel
ls implanted in nude mice), NC100150 Injection was found to cause a gradual
(over 60 min) signal increase on T1-w images in part of the tumours which
was attributed to contrast agent leakage from the vascular space to the ext
ravascular space in areas of increased capillary permeability. This observa
tion is consistent with previous reports on the molecular cut-off size for
vascular extraction for this tumour cell line. The specific enhancement of
tumour tissue suggest potential utility of NC100150 Injection as an angioge
nesis marker. (C) 2001 Elsevier Science B.V. All rights reserved.